News & Updates
Filter by Specialty:
Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes
Common blood pressure (BP)-lowering medications in pregnancy cut the risk of severe hypertension, but labetalol has the added advantage of reducing the risks of proteinuria or pre-eclampsia and perinatal death, according to the results of a network meta-analysis.
Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes
22 Feb 2022
NOACs preferable over warfarin in AF patients with bioprosthetic valves
Use of nonvitamin K oral anticoagulants (NOACs) results in a reduced incidence of thromboembolic events and major bleeding relative to warfarin in patients with atrial fibrillation (AF) and bioprosthetic valves or valve repair, suggests a study.
NOACs preferable over warfarin in AF patients with bioprosthetic valves
22 Feb 2022
Elevated dietary glycaemic index, load linked to higher CVD mortality risk
Dietary patterns with higher glycaemic index (GI) and glycaemic load (GL) appear to elevate the risk of cardiovascular disease (CVD) mortality, according to a study on Chinese adults.
Elevated dietary glycaemic index, load linked to higher CVD mortality risk
21 Feb 2022
Lipoprotein(a) molar concentrations help inform cardiovascular risk
The risk of coronary artery disease (CAD) can be predicted by a single accurate measurement of lipoprotein(a) molar concentration if therapies substantially altering lipoprotein(a) are not present, suggests a recent study.
Lipoprotein(a) molar concentrations help inform cardiovascular risk
19 Feb 2022
Edoxaban effectively keeps D-dimer low in patients with NVAF, AHF
Patients with nonvalvular atrial fibrillation (NVAF) and acute heart failure (AHF) see elevated levels of D-dimer, for which edoxaban may be effective, reports a recent study.